Details for New Drug Application (NDA): 084001
✉ Email this page to a colleague
NDA 084001 describes FERNDEX, which is a drug marketed by Ferndale Labs and is included in one NDA. Additional details are available on the FERNDEX profile page.
The generic ingredient in FERNDEX is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
The generic ingredient in FERNDEX is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
Summary for 084001
| Tradename: | FERNDEX |
| Applicant: | Ferndale Labs |
| Ingredient: | dextroamphetamine sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084001
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
